Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 111.84M
March 31, 2026 -80.03M
December 31, 2025 2.595M
September 30, 2025 -35.62M
June 30, 2025 10.71M
March 31, 2025 33.58M
December 31, 2024 19.14M
September 30, 2024 6.40M
June 30, 2024 9.606M
March 31, 2024 -27.01M
December 31, 2023 13.67M
September 30, 2023 -10.90M
June 30, 2023 -28.02M
March 31, 2023 29.97M
December 31, 2022 -15.38M
Date Value
September 30, 2022 -16.43M
June 30, 2022 -14.97M
March 31, 2022 -8.00M
December 31, 2021 14.86M
September 30, 2021 22.26M
June 30, 2021 20.50M
March 31, 2021 12.00M
December 31, 2020 -15.30M
September 30, 2020 -25.22M
June 30, 2020 -31.53M
March 31, 2020 0.00
December 31, 2019 30.13M
September 30, 2019 4.366M
June 30, 2019 -34.88M
March 31, 2019 0.00

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
InMed Pharmaceuticals, Inc. 0.00
NervGen Pharma Corp. -0.0001M
Clearmind Medicine, Inc. -0.7625M
Lexaria Bioscience Corp. -0.0271M
Target Group, Inc. (Canada) -0.0065M